Cargando…
Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
Parkinson’s disease is mainly characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Together with the small number, the high vulnerability of the dopaminergic neurons is a major pathogenic culprit of Parkinson’s disease. Our previous findings of a higher...
Autores principales: | Eyer, Gian-Carlo, Di Santo, Stefano, Hewer, Ekkehard, Andereggen, Lukas, Seiler, Stefanie, Widmer, Hans Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699585/ https://www.ncbi.nlm.nih.gov/pubmed/34943877 http://dx.doi.org/10.3390/cells10123368 |
Ejemplares similares
-
Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022) -
Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease
por: Seiler, Stefanie, et al.
Publicado: (2017) -
Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons
por: Dufour, Martial A, et al.
Publicado: (2014) -
The Role of the Substantia Nigra Pars Compacta in Regulating Sleep Patterns in Rats
por: Lima, Marcelo M.S., et al.
Publicado: (2007) -
Downregulation of thioredoxin reductase 1 expression in the substantia nigra pars compacta of Parkinson's disease mice
por: Liu, Zihua, et al.
Publicado: (2013)